The role of SRS in the management of metastatic. Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex
|
|
- Shannon James
- 5 years ago
- Views:
Transcription
1 J Neurosurg 119: , 2013 AANS, 2013 Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex Clinical article Neal Luther, M.D., 1 Douglas Kondziolka, M.D., 1,3 Hideyuki Kano, M.D., Ph.D., 1 Seyed H. Mousavi, M.D., 1 John C. Flickinger, M.D., 2 and L. Dade Lunsford, M.D. 1,2 1 Center for Image-Guided Neurosurgery, Department of Neurological Surgery, and 2 Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and 3 Department of Neurosurgery, New York University Langone Medical Center, New York, New York Object. The authors sought to better define the clinical response of patients who underwent stereotactic radiosurgery (SRS) for brain metastases located in the region of the motor cortex. Methods. A retrospective analysis was performed in 2026 patients with brain metastasis who underwent SRS with the Gamma Knife between 2002 and 2012, and multiple factors that affect motor function before and after SRS were evaluated. Ninety-four patients with tumors 1.5 cm in diameter located in or adjacent to the motor strip were identified, including 2 patients with bilateral motor strip metastases. Results. Motor function improved after SRS in 30 (31%) of 96 cases, remained stable in 48 (50%), and wors ened over time in 18 (19%) instances. Forty-seven patients had no motor weakness prior to radiosurgery; 10 (22%) developed new Grade 3/5 4/5 weakness. Thirty (68%) of 44 patients with 3/5 pre-srs weakness improved, 6 (14%) remained stable, and 8 (18%) worsened. Three of 5 patients with < 3/5 pre-srs motor function improved. Motor deficits prior to SRS did not correlate with a worse outcome; however, worse outcomes were associated with larger tumor volumes. The median tumor volume in patients whose function improved or remained stable was 5.3 cm 3, but it was 9.2 cm 3 in patients who worsened (p < 0.05). Tumor volumes > 9 cm 3 were associated with a higher risk of worsening motor function. Adverse radiation effects occurred in 5 patients. Conclusions. Most intact patients with brain metastases in or adjacent to motor cortex maintained neurological function after SRS, and most patients with symptomatic motor weakness remained stable or improved. Larger tumor volumes were associated with less satisfactory outcomes. ( Key Words eloquent area Gamma Knife tumor metastasis oncology stereotactic radiosurgery The role of SRS in the management of metastatic brain tumors continues to expand. The efficacy of SRS for brain metastases is well documented, with tumor control varying from 70% to 90%. 2,10,12,15,17,19,21,24,29 Additionally, the need for hospitalization for craniotomy or frequent visits for fractionated external-beam radiation therapy are avoided, as are neurocognitive sequelae associated with whole-brain radiation therapy. 1,4,12 Patients with brain metastases tolerate the procedure well, with generally < 10% developing any signs of adverse radiation effects 17,19,20,24,29 such as progressive peritumoral edema. Conformal and highly selective dose delivery during SRS is especially important when the tumor is located in or adjacent to critical brain anatomy such as the motor strip. 9,11 Because of concerns that SRS might worsen Abbreviation used in this paper: SRS = stereotactic radiosurgery. J Neurosurg / Volume 119 / September 2013 patients deficits for tumors in such locations, surgical removal of the tumor has been advocated to reduce local mass effect. 3,23 The goal of the current study was to define the clinical response of patients with motor strip brain metastases that were managed initially by SRS. We analyzed the response of patients with or without preexisting motor deficits and the risk of developing a new deficit after SRS. Methods We performed a retrospective analysis of 2026 patients with brain metastasis who underwent SRS with This article contains some figures that are displayed in color on line but in black-and-white in the print edition. 683
2 N. Luther et al. the Gamma Knife at the University of Pittsburgh Medical Center between 2002 and This review of patient data was approved by the institutional review board. Gamma Knife procedures were performed as we have described in prior publications. 19 All patients received a single 40-mg dose of intravenous solumedrol at the conclusion of the procedure. A postprocedure oral steroid taper was then outlined for each patient, with a goal to wean them off corticosteroids during the subsequent 3 weeks. 19,21 To meet inclusion criteria, all patients had metastatic tumors 1.5 cm in greatest dimension, and the lesions were either located within the precentral gyrus of the motor cortex or located directly adjacent to the precentral gyrus. Typical tumors are shown in Fig. 1. The motor strip was identified on imaging by using standard anatomical cues, including presence of an omega sign in the central sulcus, termination of the superior frontal sulcus into the prefrontal sulcus, and the paracentral lobule located directly anterior to the pars marginalis. No patient had undergone prior resection. All patients had pre- and postoperative neurological motor evaluations at selected intervals after the procedure. Ninety-four patients with 96 motor strip tumors (2 had bilateral tumors) were included in this evaluation. Forty-five patients were male, and the mean age was 62.6 years. The motor strip tumor was solitary in 25 patients. The most common primary metastatic cancers were lung (48 patients), breast (17 patients), melanoma (12 patients), and colon (8 patients). Pretreatment SRS motor examination, tumor volumes, and marginal radiation doses were documented. The median dose to the tumor margin was 18 Gy (range Gy). Total mean follow-up for patients following SRS was 7.3 months (range months). Follow-up examinations at 2-week, 1-month, 3-month, and 6-month intervals were available in 13%, 44%, 60%, and 43% of patients, respectively. Motor function was graded as normal (5/5), mild weakness (4/5), moderate weakness (3/5), or severe weakness (0, 1, or 2/5) in all patients according to the Medical Research Council scale (Table 1). Postprocedure motor function was analyzed at 3-month intervals Fig. 1. Typical metastatic tumors selected for SRS with the Gamma Knife are defined using a contrast-enhanced MRI with axial 2-mm slices after attachment of the stereotactic frame. A tumor directly in motor cortex is shown (left) as well as a tumor adjacent to motor cortex (right). Note that > 1.5 cm of peritumoral edema is present in the lesion in the right panel but not the one in the left panel. TABLE 1: Categorization of motor function in patients with brain metastases Motor Examination Finding* Category 4/5, 4+/5 mild 3/5 moderate 0/5, 1/5, 2/5 severe * Graded on the Medical Research Council scale. after SRS. Adverse radiation effects were defined as new motor weakness in the absence of tumor hemorrhage or enlargement. Univariate and multivariate analyses were performed to determine which patient and tumor factors corresponded to worsening functional outcome. Factors evaluated included tumor volume, margin dose, patient age, multiple versus solitary metastases, histological origin, and whether the tumor was directly in motor cortex versus adjacent to it. The rates of functional change were evaluated by Kaplan-Meier analysis. We evaluated motor outcomes in patients both with and without deficits prior to SRS. We compared tumor volumes to the motor status of patients by using a Wilcoxon signed-rank test. Motor outcomes were compared in patients with tumor volume 9 cm 3 versus those with a volume < 9 cm 3. Also, motor outcomes in patients with pre-srs peritumoral edema extending > 1.5 cm beyond the tumor margin on MRI were compared to outcomes in patients without such edema. These statistical comparisons were performed by chi-square analyses. Results Overall, motor function improved after SRS in 30 (31%), remained stable in 48 (50%), and worsened over time in 18 (19%) instances after radiosurgery. Forty-seven patients had normal motor function prior to radiosurgery, and 10 (22%) of these patients developed new mild or moderate weakness. No patient with normal motor function before SRS developed severe weakness (function < 2/5) after SRS. Forty-four patients had mild or moderate pre- SRS weakness; 27 (61%) improved, 9 (20%) remained stable, and 8 (18%) had further worsening of motor function. Two patients with mild pre-srs weakness progressed to severe weakness. Three of 5 patients with severe pre-srs weakness had improvement in motor function. Presentation with a motor deficit prior to SRS did not significantly correlate with a worsening motor function after SRS. Motor function deteriorated in 4 patients (24%) with breast cancer, in 7 patients (15%) with lung cancer, and in 4 patients (33%) who had metastatic melanoma. Motor deterioration after the procedure was significantly associated with larger tumor volumes. The mean and median tumor volumes in patients whose motor function improved or remained stable were 6.9 and 5.3 cm 3, respectively, but these volumes were 9.6 and 9.2 cm 3 in patients who had deterioration in motor function (p < 0.05). Twenty-five patients presented with a total of 27 tumors 9 cm 3 in volume, and 10 patients (37%) had wors- 684 J Neurosurg / Volume 119 / September 2013
3 Radiosurgery for motor metastases ened motor function after SRS. In comparison, in 8 (12%) of 69 tumors < 9 cm 3 treated in 68 patients, the patients developed increased weakness after radiosurgery. Tumor volumes 9 cm 3 were significantly associated with a higher risk of worsened motor function (p < 0.05). Pre-SRS peritumoral edema (defined in this report as T2 signal hyperintensity) extending > 1.5 cm beyond the mass was detected in 61 patients; 11 (18%) developed increased motor deficits after SRS. The rate of developing new or increasing motor dysfunction was not increased in patients with surrounding edema (7 [20%] of 35 such patients). Similarly, the presence of tumor directly within versus being just adjacent to motor cortex did not correlate with worsened outcome following SRS (p = 0.586). The median margin radiation dose (16 Gy) was significantly lower in patients who had delayed deterioration in motor function compared with the median margin dose delivered to patients who either remained stable or improved (18 Gy, p < 0.05). Table 2 compares motor strength after radiosurgery to preradiosurgery strength. This effect is further shown in Fig. 2. The rates of improvement and worsening following SRS are demonstrated in Fig. 3. We performed univariate and multivariate analyses of factors potentially related to motor deterioration, including tumor volume, margin dose, patient age, number of metastatic tumors, and tumor type. Univariate analysis found that tumor volume 9 cm 3 (p = 0.001), margin dose < 18 Gy (p = 0.004), and melanoma pathology (p = 0.018) were significant. Multivariate analysis found that only tumor volume 9 cm 3 was significantly associated with a worse motor outcome (p = 0.013). Motor improvement after SRS was not significantly correlated with any of these factors. Adverse radiation effects (defined as worsening neurological function associated with reactive changes on surveillance MRI in the absence of tumor growth) were seen in 5 patients. Their mean tumor volume was 8.9 cm 3 (range cm 3 ). Surgical intervention was performed in 2 patients with melanoma metastases: one patient developed an intratumoral hemorrhage and the other developed a tumor-associated cyst. Discussion The Role of Radiosurgery Radiosurgery has become a mainline management for metastatic tumors in the brain. The efficacy and safety profile of SRS for metastases is well described, and applications continue to grow. 6,13,14,20,22,25,26,30 In the past 10 years, studies have shown the potential for SRS in the Fig. 2. Bar graph in which baseline motor function prior to SRS is compared with motor function after SRS over time. The numbers lower in the bars designate improved, the numbers in the middle of the bars designate stable, and the upper numbers designate worsened. treatment of multiple metastases, larger metastases, and the tumor bed after resection. Radiosurgery is an important tool in optimizing regional control in various settings of brain metastases, and greatly increases the disease management options for such patients. Because SRS does not physically remove a metastatic tumor, successful management requires that patients have symptomatic resolution of tumor-related edema as well as a low risk of treatment-related adverse radiation effects. 7,8,16,27 In many patients radiosurgery represents the only reasonable option when tumors are located in critical brain regions such as the brainstem, diencephalon, and functional motor and speech areas. 9,11,18 Because tumors found in motor cortex represent more accessible sites for surgical removal, we sought to define the outcomes of patients who underwent primary radiosurgery instead of resection. The ability to retain or improve motor function has a major impact on subsequent quality of life in patients with brain metastases. 1,3 5,23,28 Cai et al. 3 found an increased risk of peritumoral edema after SRS for meningiomas with larger tumor volumes. Pan et al. 23 recently reported that neurocognitive outcomes were improved when Gamma Knife SRS was used, in comparison with other radiation therapy options, even in patients with significant peritumoral edema. Motor Function After Radiosurgery The results of the current study indicate that SRS provides both tumor control and a relatively low risk of developing motor deficits in most patients with motor- TABLE 2: Risk factors and association with outcomes in 96 cases of brain metastases Motor Outcome Large Vol* Edema Pre-SRS Deficit 18-Gy Margin Total improved 5 (17%) 21 (70%) not applicable 21 (70%) 30 stable 12 (25%) 29 (60%) 11 (23%) 30 (62%) 48 worsened 10 (56%) 11 (61%) 8 (44%) 6 (33%) 18 * Tumor volume > 9 cm 3. Edema extending > 1.5 cm from solid tumor margin on imaging. J Neurosurg / Volume 119 / September
4 N. Luther et al. Fig. 3. Kaplan-Meier analyses of the rate of motor function improvement in patients presenting with weakness prior to SRS (A). The rate of motor deterioration (B) following SRS to motor-region metastases is also shown. The rates of motor deterioration were significantly greater after SRS for tumors 9 cm 3 (C), those receiving < 18 Gy (D), and those patients with melanoma as primary pathology (E). region metastases. Worsening of motor function within 6 months of treatment occurred in < 20% of patients; most of whom had only mild deterioration in function. Only 2 (2%) of 91 patients without preexisting severe motor weakness developed new motor deficits after radiosurgery. Evaluation of the time course of worsened symptoms failed to reveal a clear relationship to the timing of the postprocedure evaluation. In this study SRS successfully eliminated the need for surgical removal of tumor in all but 4 patients. Predictably, as tumor volumes (and therefore treatment volumes) increased in size, more patients sustained new or worsened motor deficits. We found that patients whose tumors exceeded 9 cm 3 in volume had worsened motor outcomes. Neither the presence of a preexisting deficit, significant peritumoral edema, tumor directly in the motor cortex, primary pathology, nor higher marginal dose was associated with worse outcomes. In contrast, a higher risk of motor deterioration was associated with lower tumor marginal doses, which may be a reflection of dose reduction prescribed for larger-volume tumors. Melanoma pathology was also associated with heightened rate of motor deterioration. For patients eligible for craniotomy, it seems likely that surgical removal is the best option for tumors > 9 cm 3 in volume. Limitations of This Study The primary limitation of the current study is its retrospective nature. As a result, serial motor examinations were not truly standardized or staggered at the same intervals. In addition, examinations were not always performed by the same physician at each available time 686 J Neurosurg / Volume 119 / September 2013
5 Radiosurgery for motor metastases point. Although motor examination scores are relatively straightforward, there is always the possibility of differences in interpretation between examiners. Similarly, using MRI studies, it is relatively simple to identify lesions in proximity to the motor cortex. Dedicated functional imaging (for example, functional MRI or magnetoencephalography) in each patient might have provided a better predictive accuracy of the functional motor location. The selection of a peritumoral volume of 1.5 cm as a threshold for significant imaging-defined edema was arbitrary. Data detailing the exact timing of discontinuation of corticosteroids after SRS, and its effect on motor function, was not available in the majority of patients. Conclusions The use of SRS for motor region metastases was an effective and safe management option in the majority of patients, particularly for those with tumors < 9 cm 3. Tumors that produced local mass effect, the presence of motor dysfunction prior to SRS, and imaging evidence of peritumoral edema did not preclude successful radiosurgical management. Additional investigations that focus on quality of life and other functional outcomes after SRS, in particular those implementing standardized neurocognitive methods to determine outcome, are warranted. Disclosure Drs. Lunsford and Kondziolka are consultants for Elekta AB; Dr. Lunsford is also a stockholder in the company. Author contributions to the study and manuscript preparation include the following. Conception and design: Luther, Kondziolka, Flickinger, Lunsford. Acquisition of data: Luther, Kano, Mousavi. Analysis and interpretation of data: Luther, Kondziolka, Kano, Lunsford. Drafting the article: Luther. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Luther. Statistical analysis: Luther. Study supervision: Kondziolka, Lunsford. References 1. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68: , Auchter RM, Lamond JP, Alexander E, Buatti JM, Chap pell R, Friedman WA, et al: A multiinstitutional outcome and prog nostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35:27 35, Cai R, Barnett GH, Novak E, Chao ST, Suh JH: Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery 66: , Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain ir radiation: a randomised controlled trial. Lancet Oncol 10: , Chang EL, Wefel JS, Maor MH, Hassenbusch SJ III, Mahajan A, Lang FF, et al: A pilot study of neurocognitive function in patients with one to three new brain metastases initially J Neurosurg / Volume 119 / September 2013 treated with stereotactic radiosurgery alone. Neurosurgery 60: , Chang WS, Kim HY, Chang JW, Park YG, Chang JH: Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? Clinical article. J Neurosurg 113 Suppl:73 78, Chen CH, Shen CC, Sun MH, Ho WL, Huang CF, Kwan PC: Histopathology of radiation necrosis with severe peritumoral edema after gamma knife radiosurgery for parasagittal meningioma. A report of two cases. Stereotact Funct Neurosurg 85: , Chernov M, Hayashi M, Izawa M, Ochiai T, Usukura M, Abe K, et al: Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. Minim Invasive Neurosurg 48: , Davidson L, Zada G, Yu C, Petrovich Z, Pagnini PG, Zee CS, et al: Delayed toxicity from gamma knife radiosurgery to lesions in and adjacent to the brainstem. J Clin Neurosci 16: , Flickinger JC, Kondziolka D: Radiosurgery instead of resection for solitary brain metastasis: the gold standard redefined. Int J Radiat Oncol Biol Phys 35: , Hadjipanayis CG, Levy EI, Niranjan A, Firlik AD, Kondziolka D, Flickinger JC, et al: Stereotactic radiosurgery for motor cortex region arteriovenous malformations. Neurosurgery 48:70 77, Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD: Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52: , Jagannathan J, Yen CP, Ray DK, Schlesinger D, Oskouian RJ, Pouratian N, et al: Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. Clinical article. J Neurosurg 111: , Jensen CA, Chan MD, McCoy TP, Bourland JD, deguzman AF, Ellis TL, et al: Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. Clinical article. J Neurosurg 114: , Joseph J, Adler JR, Cox RS, Hancock SL: Linear acceleratorbased stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14: , Kamiryo T, Lopes MB, Kassell NF, Steiner L, Lee KS: Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil. Neurosurgery 49: , Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD: Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69: , Koga T, Shin M, Maruyama K, Kamada K, Ota T, Itoh D, et al: Integration of corticospinal tractography reduces motor complications after radiosurgery. Int J Radiat Oncol Biol Phys 83: , Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, et al: Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104: , Linzer D, Ling SM, Villalobos H, Raub W Jr, Wu X, Ting J, et al: Gamma knife radiosurgery for large volume brain tumors: an analysis of acute and chronic toxicity. Stereotact Funct Neurosurg 70 (Suppl 1):11 18, Niranjan A, Kano H, Khan A, Kim IY, Kondziolka D, Flickinger JC, et al: Radiosurgery for brain metastases from unknown primary cancers. Int J Radiat Oncol Biol Phys 77: , Nishizaki T, Saito K, Jimi Y, Harada N, Kajiwara K, Nomura S, et al: The role of cyberknife radiosurgery/radiotherapy for 687
6 N. Luther et al. brain metastases of multiple or large-size tumors. Minim Invasive Neurosurg 49: , Pan HC, Sun MH, Chen CC, Chen CJ, Lee CH, Sheehan J: Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo Gamma Knife surgery. J Neurosurg 109 Suppl:90 98, Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, et al: Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 101: , Rwigema JC, Wegner RE, Mintz AH, Paravati AJ, Burton SA, Ozhasoglu C, et al: Stereotactic radiosurgery to the resection cavity of brain metastases: a retrospective analysis and literature review. Stereotact Funct Neurosurg 89: , Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, et al: Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 70: , Takenaka N, Imanishi T, Sasaki H, Shimazaki K, Sugiura H, Kitagawa Y, et al: Delayed radiation necrosis with extensive brain edema after gamma knife radiosurgery for multiple cerebral cavernous malformations case report. Neurol Med Chir (Tokyo) 43: , Valéry CA, Cornu P, Noël G, Duyme M, Boisserie G, Sakka LJ, et al: Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 81: , Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD: Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 57: , Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D: What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68: , 2011 Manuscript submitted October 31, Accepted June 11, Please include this information when citing this paper: published online July 19, 2013; DOI: / JNS Address correspondence to: Hideyuki Kano, M.D., Ph.D., Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop St., Suite 400B, Pittsburgh, PA kanoh@upmc.edu. 688 J Neurosurg / Volume 119 / September 2013
Neurological Change after Gamma Knife Radiosurgery for Brain Metastases Involving the Motor Cortex
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):111-115 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.111 Neurological Change after Gamma Knife Radiosurgery for Brain Metastases
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More informationBr a i n metastases occur in 20 40% of all patients. The results of resection after stereotactic radiosurgery for brain metastases.
J Neurosurg 111:825 831, 2009 The results of resection after stereotactic radiosurgery for brain metastases Clinical article Hi d e y u k i Ka n o, M.D., Ph.D., 1,3 Do u g l a s Ko n d z i o l k a, M.D.,
More informationStereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
ONCOLOGY REPORTS 29: 407-412, 2013 Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases SHELLY LWU 1, PABLO GOETZ 1, ERIC MONSALVES 1, MANDANA ARYAEE 1, JULIUS
More informationTr a d i t i o n a l ly, WBRT has been the standard approach
Neurosurg Focus 27 (6):E7, 2009 Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy Br i a n J. Ka r l
More informationRESEARCH HUMAN CLINICAL STUDIES
TOPIC RESEARCH HUMAN CLINICAL STUDIES RESEARCH HUMAN CLINICAL STUDIES Radiosurgery to the Surgical Cavity as Adjuvant Therapy for Resected Brain Metastasis Jared R. Robbins, MD* Samuel Ryu, MD* Steven
More informationEstimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations
Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations Hideyuki Kano, MD, PhD; John C. Flickinger, MD; Daniel Tonetti, MD; Alan Hsu, MD; Huai-che
More informationLaboratory data from the 1970s first showed that malignant melanoma
2265 Survival by Radiation Therapy Oncology Group Recursive Partitioning Analysis Class and Treatment Modality in Patients with Brain Metastases from Malignant Melanoma A Retrospective Study Jeffrey C.
More informationSUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT
SUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT Cheng-Ta Hsieh, 1 Cheng-Fu Chang, 1 Ming-Ying Liu, 1 Li-Ping Chang, 2 Dueng-Yuan Hueng, 3 Steven D. Chang, 4 and Da-Tong Ju 1
More informationStereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms. Overall Clinical Significance 8/3/13
Stereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms Jason Sheehan, MD, PhD Departments of Neurosurgery and Radiation Oncology University of Virginia, Charlottesville, VA USA Overall
More informationGamma Knife Surgery for Brain Metastasis from Renal Cell Carcinoma : Relationship Between Radiological Characteristics and Initial Tumor Response
online ML Comm www.jkns.or.kr Clinical Article Jin Wook Kim, M.D. Jung Ho Han, M.D. Chul-Kee Park, M.D. Hyun-Tai Chung, Ph.D. Sun Ha Paek, M.D. Dong Gyu Kim, M.D. Department of Neurosurgery Seoul National
More informationThe role of WBRT in the management of a resected. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis
J Neurosurg 114:1585 1591, 2011 Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis Clinical article Courtney A. Jensen, M.D., 1 Michael D. Chan, M.D., 1 Thomas P. McCoy,
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 03/01/2013 Section:
More informationDisclosures. Neurological Manifestations of Von Hippel Lindau Syndrome. Objectives. Overview. None No conflicts of interest
Neurological Manifestations of Von Hippel Lindau Syndrome ARNOLD B. ETAME MD, PhD NEURO-ONCOLOGY/NEUROSURGERY Moffitt Cancer Center Disclosures None No conflicts of interest VHL Alliance Annual Family
More informationTania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015
Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015 Most common brain tumor, affecting 8.5-15% of cancer patients. Treatment options: Whole brain radiation
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationManagement of single brain metastasis: a practice guideline
PRACTICE GUIDELINE SERIES Management of single brain metastasis: a practice guideline A. Mintz MD,* J. Perry MD, K. Spithoff BHSc, A. Chambers MA, and N. Laperriere MD on behalf of the Neuro-oncology Disease
More informationLocal control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin
J Neurosurg 104:907 912, 2006 Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin MICHAEL A. VOGELBAUM, M.D., PH.D., LILYANA ANGELOV, M.D., SHIH-YUAN
More informationANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
ANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS Dr. Maitri P Gandhi 1, Dr. Chandni P Shah 2 1 Junior resident, Gujarat Cancer & Research
More informationForward treatment planning techniques to reduce the normalization effect in Gamma Knife radiosurgery
Received: 7 November 2016 Revised: 9 August 2017 Accepted: 21 August 2017 DOI: 10.1002/acm2.12193 RADIATION ONCOLOGY PHYSICS Forward treatment planning techniques to reduce the normalization effect in
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 04/01/2014 Section:
More information8/2/2018. Acknowlegements: TCP SPINE. Disclosures
A Presentation for the AAPM Annual meeting, Aug 2, 2018 Nashville, TN Stereotactic Radiosurgery for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards for Future
More informationCerebral metastases occur in 20% 40% of cancer
See the corresponding editorial, DOI: 10.3171/2012.1.JNS12103. DOI: 10.3171/2012.4.JNS11870 Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2015
More informationPrescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases
Leeman et al. Radiation Oncology 2012, 7:107 RESEARCH Open Access Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases Jonathan E Leeman
More informationOptimal Management of Isolated HER2+ve Brain Metastases
Optimal Management of Isolated HER2+ve Brain Metastases Eliot Sims November 2013 Background Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not
More informationExtracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 2, SPRING 2006 Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas Thomas Samuel Ram, a Paul B. Ravindran,
More informationFOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR PILOCYTIC ASTROCYTOMA
1 EVIDENCE SUMMARY REPORT FOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR PILOCYTIC ASTROCYTOMA QUESTIONS TO BE ADDRESSED: SUMMARY 1. What is the evidence for the clinical
More informationStereotactic Radiosurgery. Extracranial Stereotactic Radiosurgery. Linear accelerators. Basic technique. Indications of SRS
Stereotactic Radiosurgery Extracranial Stereotactic Radiosurgery Annette Quinn, MSN, RN Program Manager, University of Pittsburgh Medical Center Using stereotactic techniques, give a lethal dose of ionizing
More informationLONG-TERM FOLLOW-UP OF ACOUSTIC SCHWANNOMA RADIOSURGERY WITH MARGINAL TUMOR DOSES OF 12 TO 13 Gy
doi:10.1016/j.ijrobp.2007.01.001 Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 3, pp. 845 851, 2007 Copyright 2007 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/07/$ see front
More informationLong term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS).
Long term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS). Poster No.: C-2489 Congress: ECR 2012 Type: Scientific Exhibit Authors:
More informationDespite recent progress in microsurgical techniques, endovascular
Application of Single-Stage Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations >10 cm 3 Shunya Hanakita, MD; Tomoyuki Koga, MD, PhD; Masahiro Shin, MD, PhD; Hiroshi Igaki, MD, PhD; Nobuhito
More informationIMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE
IMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE L. D. LUNSFORD INTRODUCTION Image guided brain surgery became a reality in the mid-1970s after the introduction of the first methods to obtain axial imaging
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/20/2015
More informationResults of acoustic neuroma radiosurgery: an analysis of 5 years experience using current methods
See the Letter to the Editor and the Response in this issue in Neurosurgical Forum, pp 141 142. J Neurosurg 94:1 6, 2001 Results of acoustic neuroma radiosurgery: an analysis of 5 years experience using
More informationStereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas
Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas Treatment Results on the Basis of a 22-Year Experience Bruce E. Pollock, MD 1,2 ; Scott L. Stafford, MD
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationBrain metastases: changing visions
Brain metastases: changing visions Roberto Spiegelmann, MD Baiona, 2014 Head, Stereotactic Radiosurgery Unit Dept of Neurosurgery, Chaim Sheba Medical Center Tel Hashomer, Israel The best current estimate
More informationFOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA
1 EVIDENCE SUMMARY REPORT FOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA QUESTIONS TO BE ADDRESSED: 1. What is the evidence for the clinical effectiveness
More informationGamma Knife Radiosurgery A tool for treating intracranial conditions. CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop
Gamma Knife Radiosurgery A tool for treating intracranial conditions CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop ANGELA McBEAN Gamma Knife CNC State-wide Care Coordinator Gamma Knife
More informationStereotactic radiosurgery (SRS) has become highly
clinical article J Neurosurg 124:1018 1024, 2016 Changing practice patterns of Gamma Knife versus linear accelerator based stereotactic radiosurgery for brain metastases in the US Henry S. Park, MD, MPH,
More informationJAMA. 2006;295:
ORIGINAL CONTRIBUTION Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases A Randomized Controlled Trial Hidefumi Aoyama, MD,
More informationA method to improve dose gradient for robotic radiosurgery
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 A method to improve dose gradient for robotic radiosurgery Tianfang Li, a Cihat Ozhasoglu, Steven Burton, John Flickinger, Dwight
More informationBr a i n metastases are the tumors most frequently. Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations
J Neurosurg 113:79 83, 2010 Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations Clinical article Ni c o l a s De a, M.D., Mar t i n Bo r d u a s, Br e n d a n Ke n n y,
More informationUpdate on IGKRF Activities
Stereotactic radiosurgery research, education and publishing for the purpose of improving public health Fall 2016 In this issue: Update on IGKRF Activities The IGKRF Recently Published Articles Topics
More informationThe clinical significance of persistent trigeminal nerve contrast enhancement in patients who undergo repeat radiosurgery
CLINICAL ARTICLE J Neurosurg 127:219 225, 2017 The clinical significance of persistent trigeminal nerve contrast enhancement in patients who undergo repeat radiosurgery Seyed H. Mousavi, MD, 1 Berkcan
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017
More informationGamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival
J Neurosurg J Neurosurg (Suppl) 109:000 000, 109:99 105, 2008 Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival And y J. Re d m o n d, M.D.,
More informationLung cancer is the most common malignancy in the. Gamma Knife radiosurgery for the management of cerebral metastases from non small cell lung cancer
clinical article J Neurosurg 122:766 772, 2015 Gamma Knife radiosurgery for the management of cerebral metastases from non small cell lung cancer Greg Bowden, MD, MSc, 1,3,5 Hideyuki Kano, MD, PhD, 1,3
More informationNonsmall Cell Lung Cancer Presenting with Synchronous Solitary Brain Metastasis
1998 Nonsmall Cell Lung Cancer Presenting with Synchronous Solitary Brain Metastasis Chaosu Hu, M.D. 1 Eric L. Chang, M.D. 2 Samuel J. Hassenbusch III, M.D., Ph.D. 3 Pamela K. Allen, Ph.D. 2 Shiao Y. Woo,
More informationBrain metastases arise in 10% 40% of patients
J Neurosurg (Suppl) 117:38 44, 2012 Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone Clinical article
More informationRadioterapia degli adenomi ipofisari
Radioterapia degli adenomi ipofisari G Minniti Radiation Oncology, Sant Andrea Hospital, University of Rome Sapienza, and IRCCS Neuromed, Pozzilli (IS) Roma 6-9 Novembre 14 ! Outline " Radiation techniques
More informationSerial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma
AJNR Am J Neuroradiol 21:1540 1546, September 2000 Serial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma Hiroyuki Nakamura, Hidefumi Jokura, Kou Takahashi, Nagatoshi Boku,
More informationGamma Knife radiosurgery with CT image-based dose calculation
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Gamma Knife radiosurgery with CT image-based dose calculation Andy (Yuanguang) Xu, 1a Jagdish Bhatnagar, 1 Greg Bednarz, 1 Ajay Niranjan,
More informationInoue et al. Radiation Oncology 2014, 9:231
Inoue et al. Radiation Oncology 2014, 9:231 RESEARCH Open Access Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective
More informationMehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey
Updated Oncology 2015: State of the Art News & Challenging Topics CURRENT STATUS OF STEREOTACTIC RADIOSURGERY IN BRAIN METASTASES Mehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey Bucharest,
More information!"#$%&'()*+,-./01 !"#$ N! !"#$%&'()*+,- !"#$%&'()*+,-)*./01!"#$% &'()*+,-./#0!"#$#%
!"#$%&!"#$ N!!"#$%&'()!" N!!"#$%&'()*+,-./0123456789:;4567 OMN!"#$%!&!"#$%&'!( )*+,-./01!2345678019:;?@!ABC%6 2!"#$%&'()*!+,,-./*012345-678*4509:;?@ABC./$! -.!/0123456*+!789:6;?@A2B!#$6CD
More informationStereotactic Diffusion Tensor Tractography For Gamma Knife Stereotactic Radiosurgery
Disclosures The authors of this study declare that they have no commercial or other interests in the presentation of this study. This study does not contain any use of offlabel devices or treatments. Stereotactic
More informationOverview of MLC-based Linac Radiosurgery
SRT I: Comparison of SRT Techniques 1 Overview of MLC-based Linac Radiosurgery Grace Gwe-Ya Kim, Ph.D. DABR 2 MLC based Linac SRS Better conformity for irregular target Improved dose homogeneity inside
More informationOver the last 25 years the management options for. Stereotactic radiosurgery for arteriovenous malformations of the cerebellum.
J Neurosurg 120:583 590, 2014 AANS, 2014 Stereotactic radiosurgery for arteriovenous malformations of the cerebellum Clinical article Greg Bowden, M.D., M.Sc., 1,3,5 Hideyuki Kano, M.D., Ph.D., 1,3 Daniel
More informationSee the corresponding editorial in this issue, pp J Neurosurg 114: , 2011
See the corresponding editorial in this issue, pp 790 791. J Neurosurg 114:792 800, 2011 Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer Clinical article
More informationSelecting the Optimal Treatment for Brain Metastases
Selecting the Optimal Treatment for Brain Metastases Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Understand the benefits, limitations,
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationHong Kong Hospital Authority Convention 2018
Hong Kong Hospital Authority Convention 2018 Stereotactic Radiosurgery in Brain Metastases - Development of the New Treatment Paradigm in HA, Patients Profiles and Their Clinical Outcomes 8 May 2018 Dr
More informationSpetzler-Martin Grade III arteriovenous malformations. Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations.
See the corresponding editorial in this issue, pp 955 958. J Neurosurg 120:959 969, 2014 AANS, 2014 Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations Clinical article Dale Ding, M.D.,
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM BRAIN METASTASES CNS Site Group Brain Metastases Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationA prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors
J Neurooncol (2012) 109:159 165 DOI 10.1007/s11060-012-0882-8 CLINICAL STUDY A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors Shoji Yomo Motohiro Hayashi Claire
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationCyberknife Radiotherapy for Vestibular Schwannoma
Cyberknife Radiotherapy for Vestibular Schwannoma GordonT. Sakamoto, MD a, *, Nikolas Blevins, MD b, Iris C. Gibbs, MD c KEYWORDS Stereotactic radiosurgery Vestibular schwannomas Cyberknife Fractionation
More informationPotential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases
clinical article J Neurosurg 123:1261 1267, 2015 Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases *Jessica M. Frakes, MD,
More informationSTEREOTACTIC RADIOSURGERY FOR LIMITED BRAIN METASTASES IN IRANIAN BREAST CANCER PATIENTS
STEREOTACTIC RADIOSURGERY FOR LIMITED BRAIN METASTASES IN IRANIAN BREAST CANCER PATIENTS Yousefi Kashi A. SH, Mofid B. 1 Department of Radiation Oncology,Shohada Tajrish Hospital,Shahid Beheshti University
More informationSergio Bracarda MD. Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy
Sergio Bracarda MD Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy Ninth European International Kidney Cancer Symposium Dublin 25-26
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationCase Report Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell Carcinoma
Case Reports in Neurological Medicine Volume 2015, Article ID 872915, 5 pages http://dx.doi.org/10.1155/2015/872915 Case Report Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationOutcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer Patients with Multiple Brain Metastases
ORIGIL ARTICLE Brain Tumor Res Treat 2013;1:64-70 / Print ISSN 2288-2405 / Online ISSN 2288-2413 online ML Comm Outcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer
More informationAc o u s t i c neuromas, also known as vestibular. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma
J Neurosurg 111:863 873, 2009 Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma Clinical article Hi d e y u k i Ka n o, M.D., Ph.D., 1,3 Do u g l a s Ko n d z i o
More informationA new score predicting the survival of patients with spinal cord compression from myeloma
Douglas et al. BMC Cancer 2012, 12:425 RESEARCH ARTICLE Open Access A new score predicting the survival of patients with spinal cord compression from myeloma Sarah Douglas 1, Steven E Schild 2 and Dirk
More informationDifferentiation of radionecrosis from tumor recurrence
Neuro-Oncology 15(12):1732 1738, 2013. doi:10.1093/neuonc/not130 NEURO-ONCOLOGY Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationSpecialised Services Policy: CP22. Stereotactic Radiosurgery
Specialised Services Policy: CP22 Document Author: Assistant Director of Planning Executive Lead: Director of Planning ad Performance Approved by: Management Group Issue Date: 01 July 2015 Review Date:
More informationORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY
Nagoya J. Med. Sci. 76. 27 ~ 33, 2014 ORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY HISATO NAKAZAWA 1,2, MSc; YOSHIMASA
More informationParaganglioma of the Skull Base. Ross Zeitlin, MD Medical College of Wisconsin Milwaukee, WI
Paraganglioma of the Skull Base Ross Zeitlin, MD Medical College of Wisconsin Milwaukee, WI Case Presentation 63-year-old female presents with right-sided progressive conductive hearing loss for several
More informationThe Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations
The new england journal of medicine original article The Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations Keisuke Maruyama, M.D., Nobutaka Kawahara, M.D., Ph.D., Masahiro
More informationTreatment of Brain Metastases
1 Treatment of Brain Metastases An Overview and Pending Research Questions To Answer Olav E. Yri, MD, PhD www.ntnu.no/prc European Palliative Care Research Centre (PRC) The brain metastases diagnosis Outline
More informationBrain metastases are the most frequent intracranial
J Neurosurg (Suppl 2) 121:75 83, 2014 AANS, 2014 Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis Clinical article Eric Ojerholm, M.D.,
More informationAlleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen?
Department of Radiation Oncology Chairman: Prof. Dr. Matthias Guckenberger Alleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen? Matthias
More informationOtolaryngologist s Perspective of Stereotactic Radiosurgery
Otolaryngologist s Perspective of Stereotactic Radiosurgery Douglas E. Mattox, M.D. 25 th Alexandria International Combined ORL Conference April 18-20, 2007 Acoustic Neuroma Benign tumor of the schwann
More informationOutline. WBRT field. Brain Metastases. Whole Brain RT Prophylactic WBRT Stereotactic radiosurgery (SRS) 1 fraction Stereotactic frame
Radiation Therapy for Advanced NSC Lung Ca Alexander Gottschalk, M.D., Ph.D. Associate Professor Director of CyberKnife Radiosurgery Department of Radiation Oncology University of California San Francisco
More informationBrain metastases are common brain malignant neoplasms
J Neurosurg (Suppl) 117:49 56, 2012 Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non small cell lung cancer
More informationPre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases
Aliabadi et al. Chinese Neurosurgical Journal (2017) 3:29 DOI 10.1186/s41016-017-0092-5 CHINESE NEUROSURGICAL SOCIETY RESEARCH CHINESE MEDICAL ASSOCIATION Pre-operative stereotactic radiosurgery treatment
More informationThe incidence of malignant melanoma is among the. Surgical management of melanoma brain metastases in patients treated with immunotherapy
J Neurosurg 115:30 36, 2011 Surgical management of melanoma brain metastases in patients treated with immunotherapy Clinical article Russell R. Lonser, M.D., 1 Debbie K. Song, M.D., 1 Jacob Klapper, M.D.,
More informationGamma Knife Treatment of Brainstem Metastases
Int. J. Mol. Sci. 2014, 15, 9748-9761; doi:10.3390/ijms15069748 Article OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Gamma Knife Treatment of Brainstem
More informationA lthough more than 90% of intracranial meningiomas are
226 PAPER Complications after gamma knife radiosurgery for benign meningiomas J H Chang, J W Chang, J Y Choi, Y G Park, S S Chung... See end of article for authors affiliations... Correspondence to: Professor
More informationDisclosure SBRT. SBRT for Spinal Metastases 5/2/2010. No conflicts of interest. Overview
Stereotactic Body Radiotherapy (SBRT) for Recurrent Spine Tumors Arjun Sahgal M.D., F.R.C.P.C. Assistant Professor Princess Margaret Hospital Sunnybrook Health Sciences Center University of Toronto Department
More informationLeptomeningeal Carcinomatosis: Risks, Detection, and Treatment. Goldie Kurtz, MD, FRCPC Department of Radiation Oncology University of Pennsylvania
Leptomeningeal Carcinomatosis: Risks, Detection, and Treatment Goldie Kurtz, MD, FRCPC Department of Radiation Oncology University of Pennsylvania May 13, 2016 Disclosures None to declare 2 Outline Epidemiology
More information